Regional Clinical Diagnostics Lab: 65% faster treatment decisions with Tempus AI

Overview

Regional Clinical Diagnostics Lab faced a critical challenge: AI-powered analysis of patient genomic data to identify actionable biomarkers and match patients to optimal therapies. After evaluating multiple solutions, they selected Tempus AI for its proven track record in diagnostic & clinical labs. The results were significant: 65% faster treatment decisions within the first year of deployment. This case study explores the implementation journey, results achieved, and lessons learned.

Background & Challenge

As a 500 employees, 200+ test menu diagnostic & clinical labs organization, Regional Clinical Diagnostics Lab operates in a highly competitive market where efficiency and service quality directly impact profitability. AI-powered analysis of patient genomic data to identify actionable biomarkers and match patients to optimal therapies. After analyzing the total cost of inefficiency, leadership determined that modernization was not optional but essential for survival and growth.

Solution & Implementation

The implementation of Tempus AI followed a phased approach over 10 weeks including regulatory approval. Conducted requirements analysis and system design. Integrated with existing infrastructure and data sources. Configured AI models and business rules. Cross-functional teams collaborated throughout the deployment. This methodical approach minimized disruption while building organizational confidence in the new system.

Results & Impact

The deployment delivered significant measurable results across multiple dimensions. **Time to Treatment Decision**: Improved from 4-6 weeks to 1-2 weeks, achieving 65% faster treatment decisions. **Treatment Response Rate**: Improved from 20-30% standard of care to 50-70% biomarker-guided, achieving 2x improvement in response rate. **Clinical Trial Matching**: Improved from 5% of eligible patients enrolled to 15-25% of eligible patients enrolled, achieving 3-5x increase in trial enrollment. These improvements validated the business case and exceeded initial projections. As the Chief Scientific Officer noted: "Tempus AI transformed our approach to molecular design. We now explore chemical space orders of magnitude faster than with conventional methods."

Key Takeaways

Regional Clinical Diagnostics Lab's experience offers valuable insights for other diagnostic & clinical labs organizations. Wet-lab validation must be tightly integrated with computational workflows for iterative improvement. Change management is critical — scientists need training and trust-building with AI-generated results. Cross-functional teams spanning computational and experimental expertise drive the best outcomes. Success requires executive sponsorship, cross-functional collaboration, and commitment to continuous improvement. The measurable results—65% faster treatment decisions—demonstrate that AI investments in diagnostic & clinical labs deliver rapid, quantifiable returns when implemented thoughtfully.